Released 24 August 2023
The Government has released key documents that led to its decision to amend the Therapeutic Products Bill to create an exemption regime for small-scale natural health product (NHP) producers and remove most obligations for rongoā.
We have released:
- advice provided to the Minister on direct to consumer advertising of prescription medicines (DTCA-PM)
- and a Regulatory Impact Statement (RIS) which provides analysis on both small-scale Natural Health Product (NHP) manufacturers and rongoā.
The Ministry’s Māori Health Directorate (Te Pou Hauora) has also released documents relating to advice given from the rongoā workstream to Ministers during development of the Act.
Released 13 June 2023
This set of documents was published on the New Zealand Parliament website.
- Health Committee’s report back on the Bill
- Manatū Hauora Initial Briefing (PDF, 1.1 MB)
- Manatū Hauora Departmental Report (PDF, 1.1 MB)
- Appendix 2 (clause by clause analysis) (PDF, 2.5 MB)
- Appendix 3 (response to questions from Oral Hearings) (PDF, 170 KB)
- Appendix 4 (Response to the Legislative Scrutiny Memo) (PDF, 844 KB)
- Appendix 5 (response to Regulations Review Committee) (PDF, 548 KB)
- Appendix 6 (Literature Review – Evidence of harm from NHPs) (PDF, 428 KB)
- Appendix 7 (Literature Review – DTCA-PM) (PDF, 345 KB)
Released 17 January 2023
- Cabinet paper: Therapeutic Products Bill: Approval for introduction (PDF, 712 KB)
- Legislation Committee minute: Therapeutic Products Bill: Approval for introduction (PDF, 673 KB)
- Cabinet minute: Therapeutic Products Bill: Approval for introduction (PDF, 684 KB)
Released 30 November 2022
- Regulatory Impact Statement: Therapeutic and Natural Health Products Regulation – Supplementary Analysis 2022 No 1
- Regulatory Impact Statement: Therapeutic and Natural Health Products Regulation – Supplementary Analysis 2022 No 2
- Cabinet paper: Pharmacy Ownership and Licensing (PDF, 663 KB)
- Cabinet minute: Pharmacy Ownership and Licensing (PDF, 660 KB)
- Regulatory Impact Statement: Pharmacy Ownership and Licensing
- Cabinet paper: Crown Liability under the Therapeutic Products Bill and Other Offence and Penalty Matters (PDF, 706 KB)
- Cabinet minute: Crown Liability under the Therapeutic Products Bill and Other Offence and Penalty Matters (PDF, 652 KB)
- Cabinet paper: Therapeutic Products and Natural Health Products Regulatory Scheme (PDF, 854 KB)
- Cabinet minute: Therapeutic Products and Natural Health Products Regulatory Scheme (PDF, 662 KB)
Released 17 March 2022
- Cabinet paper: Regulating Natural Health Products (PDF, 306 KB)
- Cabinet minute: Regulating Natural Health Products (PDF, 118 KB)
- Regulatory Impact Statement: Regulating natural health products
Released 14 December 2018
- Cabinet paper: Therapeutic Products Regulatory Scheme: Overview and Consultation on Bill Exposure Draft (PDF, 191 KB)
- Cabinet minute: Therapeutic Products Regulatory Scheme: Overview and Consultation on Bill Exposure Draft (PDF, 128 KB)
- Regulatory impact statement: Therapeutic Products Bill – Personal Import of Medicine by mail/courier
Minutes from November 2015 and March 2016 Cabinet papers
- Cabinet minute: Therapeutic Products Regulation Paper 1: Context and Overview (PDF, 144 KB)
- Cabinet minute: Therapeutic Products Regulation Paper 2: Proposals for a Therapeutic Products Bill (PDF, 141 KB)
- Cabinet minute: Therapeutic Products Regulation: Further Policy Approvals (PDF, 150 KB)
Released 28 April 2016
- Therapeutic Products Regulation Paper 1: Context and Overview (Word, 35 KB)
- Therapeutic Products Regulation Paper 2: Proposals for a Therapeutic Products Bill (Word, 157 KB)
- Regulatory Impact Statement 1 (for Cabinet Papers 1 and 2)
- Therapeutic Products Regulation Paper 3: Further Policy Approvals (Word, 46 KB)
- Appendix 1 for Cabinet Paper 3: A3 (PowerPoint, 68 KB)
- Regulatory Impact Statement 2 (for Cabinet Paper 3)